Medicare Part D low-income subsidies alone are insufficient to improve the uptake and equitable use of high-cost, orally administered antimyeloma therapy.
State-Level Projections of Cancer-Related Medical Care Costs: 2010 to 2020
State-level estimates of the number of people treated for cancer and the average cost of their treatment by state from 2010 through 2020.
The Personal Financial Burden of Cancer for the Working-Aged Population
Being actively treated for cancer increases the mean annual out-of-pocket medical expenditures by $1170 compared with not having cancer.